+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Doripenem"

4-AA for Carbapenem Antibiotic Market by Molecule (Biapenem, Doripenem, Ertapenem), Dosage Form (Capsule, Injection Solution, Powder for Injection), Distribution Channel, End User, Route, Indication - Global Forecast 2025-2030 - Product Thumbnail Image

4-AA for Carbapenem Antibiotic Market by Molecule (Biapenem, Doripenem, Ertapenem), Dosage Form (Capsule, Injection Solution, Powder for Injection), Distribution Channel, End User, Route, Indication - Global Forecast 2025-2030

  • Report
  • August 2025
  • 188 Pages
  • Global
From
Semi-synthetic ß-lactam Antibiotics Market by Product Type (Carbapenem Derivatives, Cephalosporin Derivatives, Monobactam Derivatives), Route of Administration (Oral, Parenteral), End User, Distribution Channel, Indication - Global Forecast 2025-2030 - Product Thumbnail Image

Semi-synthetic ß-lactam Antibiotics Market by Product Type (Carbapenem Derivatives, Cephalosporin Derivatives, Monobactam Derivatives), Route of Administration (Oral, Parenteral), End User, Distribution Channel, Indication - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Intra-abdominal Infections Market by Antibiotic Class (Carbapenems, Cephalosporins, Penicillins), Infection Type (Community Acquired, Hospital Acquired), Pathogen Type, Patient Age Group, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Intra-abdominal Infections Market by Antibiotic Class (Carbapenems, Cephalosporins, Penicillins), Infection Type (Community Acquired, Hospital Acquired), Pathogen Type, Patient Age Group, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class (Carbapenems, Cephalosporins, Monobactam), Route of Administration (Oral Administration, Parenteral Administration), Patient Type, Application, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class (Carbapenems, Cephalosporins, Monobactam), Route of Administration (Oral Administration, Parenteral Administration), Patient Type, Application, End User - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Carbapenem Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Carbapenem Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Carbapenem-Based Antibiotic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Carbapenem-Based Antibiotic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Report 2025 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel

  • Report
  • February 2022
  • 180 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Doripenem is an antibiotic used to treat a variety of bacterial infections. It belongs to the carbapenem class of antibiotics, which are broad-spectrum antibiotics used to treat serious infections caused by a wide range of bacteria. Doripenem is effective against both Gram-positive and Gram-negative bacteria, and is used to treat infections of the urinary tract, lower respiratory tract, skin, and soft tissue. It is also used to treat complicated intra-abdominal infections. Doripenem is administered intravenously and is generally well tolerated, with few side effects. Doripenem is a relatively new antibiotic, and is not widely used. It is used mainly in hospitals, where it is used to treat serious infections that are resistant to other antibiotics. It is also used in combination with other antibiotics to treat infections that are difficult to treat. Several companies are involved in the production and distribution of Doripenem. These include Merck & Co., Inc., Pfizer, Inc., AstraZeneca, and GlaxoSmithKline. Show Less Read more